REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 102 filers reported holding REGULUS THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,000 | -88.9% | 1,649 | -92.9% | 0.00% | -100.0% |
| Q4 2016 | $18,000 | -76.9% | 23,249 | -40.5% | 0.00% | -66.7% |
| Q3 2016 | $78,000 | -34.5% | 39,049 | -29.3% | 0.00% | -50.0% |
| Q2 2016 | $119,000 | -33.9% | 55,249 | +43.0% | 0.01% | -50.0% |
| Q1 2016 | $180,000 | +172.7% | 38,649 | +277.1% | 0.01% | +300.0% |
| Q4 2015 | $66,000 | – | 10,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |